News

Extendicare Announces Timing of 2023 Third Quarter Results and Conference Call

MARKHAM, Ontario, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it…

10 months ago

Lowell Farms Inc. Announces Repurchase of $22 Million of Senior Secured Convertible Debentures

California cannabis leader repurchases all outstanding senior secured convertible indebtednessSALINAS, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Lowell Farms Inc.…

10 months ago

LSL Pharma Group Engages Paradox as Investor Relations Services Provider

BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma…

10 months ago

Applied UV to Introduce Airocide® Pro+ Air Food Preservation Solution Designed to Control Ethylene Levels and Extend Shelf Life at the Global Produce & Floral Show, Together With Canon Virginia, a Subsidiary of Canon U.S.A.

Applied UV, Inc. Airocide® Pro+ Applications Across the Food Supply and Logistics ChainRemoving Ethylene, a Gas Produced Naturally, is Critical…

10 months ago

Immunocore announces upcoming presentation and posters at ESMO 2023

Immunocore announces upcoming presentation and posters at ESMO 2023 Long-term survival data for KIMMTRAK in previously untreated patients with metastatic…

10 months ago

US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

LONDON and SALT LAKE CITY, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company…

10 months ago

The Ensign Group Acquires Skilled Nursing Facility in Kansas

SAN JUAN CAPISTRANO, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group…

10 months ago

Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023

LONDON and RALEIGH, N.C., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”),…

10 months ago

Spexis to host business update conference call on October 9, 2023

ALLSCHWIL, Switzerland, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics…

10 months ago